- Home
- FONR vs INCR Comparison
FONR vs INCR Comparison
Compare FONR & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- INCR
- Stock Information
- Founded
- FONR 1978
- INCR 1994
- Country
- FONR United States
- INCR Israel
- Employees
- FONR N/A
- INCR N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- FONR Health Care
- INCR Health Care
- Exchange
- FONR Nasdaq
- INCR Nasdaq
- Market Cap
- FONR 100.6M
- INCR 82.3M
- IPO Year
- FONR 1987
- INCR N/A
- Fundamental
- Price
- FONR $14.70
- INCR $1.35
- Analyst Decision
- FONR
- INCR
- Analyst Count
- FONR 0
- INCR 0
- Target Price
- FONR N/A
- INCR N/A
- AVG Volume (30 Days)
- FONR 14.8K
- INCR 25.9K
- Earning Date
- FONR 09-26-2025
- INCR 10-08-2025
- Dividend Yield
- FONR N/A
- INCR N/A
- EPS Growth
- FONR N/A
- INCR N/A
- EPS
- FONR 1.26
- INCR N/A
- Revenue
- FONR $104,351,318.00
- INCR $72,158,312.00
- Revenue This Year
- FONR N/A
- INCR $69.54
- Revenue Next Year
- FONR N/A
- INCR $41.75
- P/E Ratio
- FONR $11.66
- INCR N/A
- Revenue Growth
- FONR 1.43
- INCR N/A
- 52 Week Low
- FONR $12.00
- INCR $1.17
- 52 Week High
- FONR $17.62
- INCR $1.79
- Technical
- Relative Strength Index (RSI)
- FONR 32.90
- INCR 34.81
- Support Level
- FONR $14.71
- INCR $1.32
- Resistance Level
- FONR $14.97
- INCR $1.46
- Average True Range (ATR)
- FONR 0.24
- INCR 0.05
- MACD
- FONR -0.08
- INCR -0.01
- Stochastic Oscillator
- FONR 0.00
- INCR 13.64
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.